Impaired Cerebrovascular Reactivity in Patients With Atrial Fibrillation.

[1]  C. Albert,et al.  Differences in Risk of Sudden Cardiac Death Between Blacks and Whites. , 2018, Journal of the American College of Cardiology.

[2]  R. Cooper,et al.  Race, Ancestry, and Reporting in Medical Journals. , 2018, JAMA.

[3]  R. Cooper,et al.  Nature versus Nurture in the Explanations for Racial/Ethnic Health Disparities , 2018 .

[4]  N. Krieger,et al.  Structural racism and health inequities in the USA: evidence and interventions , 2017, The Lancet.

[5]  M. Rutten,et al.  Novel monorail infusion catheter for volumetric coronary blood flow measurement in humans: in vitro validation. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[6]  D J Mikulis,et al.  Measuring cerebrovascular reactivity: what stimulus to use? , 2013, The Journal of physiology.

[7]  G. Lip,et al.  The endothelium and atrial fibrillation , 2008, Hämostaseologie.

[8]  Frans van de Vosse,et al.  Direct volumetric blood flow measurement in coronary arteries by thermodilution. , 2007, Journal of the American College of Cardiology.

[9]  Leo Celi,et al.  Human cerebrovascular and ventilatory CO2 reactivity to end‐tidal, arterial and internal jugular vein PCO2 , 2007, The Journal of physiology.

[10]  J. Seward,et al.  Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohort. , 2007, European heart journal.

[11]  Ganesh Manoharan,et al.  Assessment of renal artery stenosis severity by pressure gradient measurements. , 2006, Journal of the American College of Cardiology.

[12]  C Caltagirone,et al.  Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. , 2000, JAMA.